WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced its innovative RapidFire® High-Throughput Mass Spectrometry (RF-MS) screening platform was installed in its first European customer site at Boehringer Ingelheim in Biberach, Germany. The RapidFire system, which is being used for expanded in vitro ADME applications at Boehringer Ingelheim recently received Conformité Europeene (CE) and ETL Marks acknowledging mandated health, safety and environmental requirements were met, enabling marketing distribution across the European Union and in Canada. A second RapidFire system was also installed at Boehringer Ingelheim’s Laval, Canada site.
